Methotrexate Injectable bulk supplier for pharma manufacturers

Methotrexate Injectable Suppliers & Bulk Manufacturers

Available Forms: Injectable (IV, IM, Subcutaneous)

Available Strengths: 25 mg/mL, 50 mg/mL, 250 mg/10 mL vial

Reference Brands: Trexall (US)

Category: Arthritis

Methotrexate injectable inhibits dihydrofolate reductase, blocking DNA synthesis and cell reproduction. It reduces inflammation and suppresses immune activity, making it effective for rheumatoid arthritis and cancer. Benefits include rapid action, versatile administration, disease modulation, and improved joint function in RA, with a proven safety profile when monitored properly.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Methotrexate injectable is approved in the EU and US for treating rheumatoid arthritis, cancer, and autoimmune diseases. In the EU, Pfizer’s Trexall and other generics are regulated by EMA, supported by dossiers demonstrating safety, quality, and efficacy. In the US, FDA approval is based on comprehensive clinical data and biosimilarity assessments. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, registration, and compliance, visit PharmaTradz. We support efficient market access for methotrexate injectable formulations, ensuring adherence to European and American standards for safe, effective treatment of autoimmune and oncological conditions.

Methotrexate Injectable — third party manufacturing & bulk supply

Methotrexate Injectable is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Methotrexate Injectable is supplied as Injectable (IV, IM, Subcutaneous) — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Methotrexate Injectable listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Methotrexate Injectable →

Back to Listing

Frequently Asked Questions

Methotrexate Injectable is listed as Injectable (IV, IM, Subcutaneous) in 25 mg/mL, 50 mg/mL, 250 mg/10 mL vial. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Methotrexate Injectable is referenced against Trexall (US). Reference brands are shown for identification only and remain the property of their respective trademark owners.